Worldline reported Q3 2024 sales of €1,163 million, reflecting an organic decline of -1.1%. Following this, UBS has reiterated its Sell recommendation and reduced the target price to €5, indicating a potential downside of -18%. Despite revenue challenges, Worldline maintains its fiscal 2024 guidance, aiming for around 1% organic sales growth and adjusted EBITDA of approximately €1.1 billion.